Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reissue Patent
2007-02-27
2007-02-27
Minnifield, N. M. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S184100, C424S203100, C424S234100, C424S254100, C424S255100, C424S253100, C424S240100, C424S825000, C424S093100, C424S093300, C435S236000, C435S235100, C435S253100, C435S243000, C435S245000, C435S237000, C435S238000
Reissue Patent
active
10914024
ABSTRACT:
The invention relates to a method for making an inactivated vaccine ofMycoplasma hyopneumoniaeby inactivating the bacteria with Thimerosal. The resulting bacterin is mixed with an adjuvant of aluminum hydroxide and DEAE dextran and injected into pigs. The resulting bacterin and adjuvant mixture can also be mixed with other bacteria such as Bordetella and Pasteurella, for further adjuvant effect. Protective immunity against mycoplasmal pneumonia is elicited in swine using these vaccines.
REFERENCES:
patent: 2908614 (1959-10-01), Muggleton et al.
patent: 3522790 (1970-08-01), Cambre et al.
patent: 3917819 (1975-11-01), Yoshioka et al.
patent: 4058599 (1977-11-01), Bauer et al.
patent: 4855227 (1989-08-01), McGarrity et al.
patent: 4894332 (1990-01-01), Schaller et al.
patent: 4981684 (1991-01-01), MacKenzie et al.
patent: 4985243 (1991-01-01), Faulds et al.
patent: 5004607 (1991-04-01), Ragland et al.
patent: 5064647 (1991-11-01), Storm
patent: 5338543 (1994-08-01), Fitzgerald et al.
patent: 5536496 (1996-07-01), Frantz et al.
patent: 5695769 (1997-12-01), Frantz et al.
patent: 5925359 (1999-07-01), Van Woensel et al.
patent: 6113916 (2000-09-01), Bhogal et al.
patent: 6517843 (2003-02-01), Ellis et al.
patent: 6585981 (2003-07-01), Pijoan
patent: 2003/0017171 (2003-01-01), Chu et al.
patent: 2005/0123550 (2005-06-01), Laurent et al.
patent: 2005/0163791 (2005-07-01), Adler et al.
patent: 2005/0220814 (2005-10-01), Dominowski et al.
patent: 2005/0255121 (2005-11-01), Campbell et al.
patent: 0196215 (1986-10-01), None
patent: 0325191 (1989-07-01), None
patent: 0345021 (1989-12-01), None
patent: 0359919 (1990-06-01), None
patent: 4359919 (1990-06-01), None
patent: 0415794 (1990-08-01), None
patent: 0415794 (1991-03-01), None
patent: 0475185 (1992-03-01), None
patent: 0283840 (1998-09-01), None
patent: 26334 (1979-03-01), None
patent: WO 8600019 (1986-01-01), None
patent: 2800911 (1988-02-01), None
patent: WO 8800971 (1988-02-01), None
patent: WO 91/03256 (1991-03-01), None
patent: WO 9/11717 (1991-08-01), None
patent: 7111717 (1991-08-01), None
patent: WO 9/18627 (1991-12-01), None
patent: 7118627 (1991-12-01), None
patent: 7203157 (1992-03-01), None
patent: WO 9/203157 (1992-03-01), None
Dayalu et al, Proceedings 8thCongress Federation Asian Vet. Assn., 1992, pp. 254-260.
Petersen et al, International Pig Vet. Soc. 11thCongress Proceedings, Jul. 1-5, 1990, p. 84.
Maes et al, J. Vet. Med., 1998, 45:495-505.
Dayalu et al, International Pig Vet. Soc. 11th Congress Proceedings, Jul. 1-5, 1990, p. 83.
Kolodziejczyk et al, Medycyna Weterynaryjna, 2002, 58/6:448-452.
Sheldrake et al, Research in Vet. Sci., 1991, 51:285-291.
Slavik et al, Iowa State Journal Research, May 1979, 53/4:297-300.
Fitzgerald et al, Agri-Practice, Jan./Feb. 1990, 11/1:25-29.
Leibl et al, Vaccine, 1999, 17:1017-1023.
Kristensen et al, Am. J. Vet. Res., May 1981, 42/5:784-788.
Messier et al, Am. J. Vet. Res., Jan. 1990, 51/1:52-58.
Moreau et al, Vaccine, 2004, 22:2328-2333.
Escobar et al, J. Animal Science, 2002, 80:384-391.
Haesebrouck et al, Vet. Microbiology, 2004, 100:255-268.
Sorensen et al, Vet. Microbiolgy, 1997, 54:23-34.
Pfuetzner et al, Tieraerztliche Umschau, 1995, 50/11:759-765 Abstract only.
Murphy, Dissertation Abstracts International, 1994, 55/8B:3188 Abstract only.
Stipkovits et al, Magyar Allatorvosok Lapja, Nov. 1997, 119/11:663-671.
Johnson et al, Vet. Medicine, Apr. 1992, pp. 382-386.
Fitzgerald et al, Vet. Medicine, Jan. 1988, pp. 80-82, 84, 86.
Awad-Masalmeh et al, “Uber chronisch—respiratorische Erkrankungen beim Schwein in Osterreich”, Wein. Tierarztl. Mschr., 1990, 77:88-93 partial English translation.
Kishima et al, “Humoral Immune Response to Non-Viable Mycoplasma Pulmonis in Mice . . . ,” Veterinary Micorbio. (1987) 13:335-43.
Peterson et al, “Response toMycoplasma HyopneumoniaeVaccination in Nursing Piglets”, Proc. Amer. Assoc. Swine Pract. (Mar. 1991) pp. 17-21.
Gupta et al, Biological Abstracts, (1986) 82/11:102519.
Wise et al, “Major Membrane Surface Proteins of Mycoplasma . . . ,” Journal of Bacteriology, (1987) V169 N12, pp. 5546-5555.
Friis, N.F., “Mycoplasmas Cultivated from the Respiratory Tract of Danish Pigs”, Acta vet. Scand. 1971, 12, pp. 69-79.
Mattsson, J.G., et al. “Detection ofMycoplasma hyopneumoniaein Nose Swabs from Pigs by In Vitro Amplification of . . . ” J. of Clinical Microbiology Apr. 1995 pp. 893-897, V33, N4.
Baumeister, A.K. et al. “Detection ofMycoplasma hyopneumoniaein Bronchoalveolar Lavage Fluids of Pigs by PCR” J. of Clinical Microbiology, Jul. 1998, pp. 1984-1988, V36, N7.
Stenke, G.W. et al. “Differentiation ofMycoplasma hyopneumoniae, M. flocculare,andM. hyorhinison the basis of amplification . . . ” Am. J. Vet. Res. Jan. 1994, pp. 81-84, V55, N1.
Lam, K.M. et al. “Mycoplasmal Pneumonia of Swine: Active and Passive Immunizations” Am. J. Vet. Res., Nov. 1971, pp. 1737-1741, V32, N11.
Peterson et al.Proc. Amer. Assoc. Swine Pract, Mar. 1991, 1976.
Gupta, R. et al, Biological Abstracts, (1986) 82/11:102519.
Mirchansy, H. A. et al, Biological Abstracts (1976) 62/8:43171.
Wise et al.Journal of Bacteriology, 169: 5546-5555 (1987).
Peterson et al.Proc. Amer. Assoc. Swine Pract, Mar. 1991, pp. 17-21 1976.
Dayalu, Proceedings: Mycoplasma Pneumonia Symposium, Smith Kline Beecham, (1990) 1-15.
Kishma et al.Veterinary Microbiology. 13: 335-42 (1987).
Fitzgerald Gerald R.
Welter C. Joseph
Blackstone William M.
Intervet Inc.
Minnifield N. M.
LandOfFree
Inactivated mycoplasma hyopneumoniae and uses therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inactivated mycoplasma hyopneumoniae and uses therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inactivated mycoplasma hyopneumoniae and uses therefor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3857986